Physician
Ayoub, Mona
Ayoub, Mona was paid $4.00M by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoAYOUB, MONA
BROOKLYN, NY 11212
BROOKLYN, NY 11212
33aNPI1114199551assigned 03/26/2008
33bProvider typePediatrics Physician
28Total paid$4.00M
24GClaims104,087
24DCodes billed47
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#82 of 1,983
Median peer was paid$17K
This provider vs. median236×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,922 | $677K | |
| 2019 | 14,304 | $618K | |
| 2020 | 13,713 | $542K | |
| 2021 | 13,158 | $566K | |
| 2022 | 18,446 | $636K | |
| 2023 | 16,157 | $550K | |
| 2024incomplete | 11,387 | $407K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 29,756 | 24,208 | $1.55M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 12,697 | 11,840 | $911K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.5% | 13,458 | 12,376 | $300K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.4% | 3,927 | 3,819 | $254K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 3,121 | 3,043 | $206K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.2% | 2,731 | 2,547 | $166K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.8% | 4,597 | 4,231 | $153K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.3% | 5,481 | 4,429 | $134K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 11,375 | 6,723 | $101K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 1,365 | 1,335 | $90K |
| 90658 | <1% | 1,824 | 1,770 | $28K | |
| 90651 | <1% | 406 | 392 | $18K |
35 more codes
| 90670 | <1% | 360 | $11K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,409 | $11K |
| 90716 | <1% | 233 | $6K | |
| 99401 | <1% | 444 | $6K | |
| 90713 | <1% | 1,165 | $6K | |
| 90677 | <1% | 111 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 993 | $5K |
| 90700 | <1% | 1,043 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 84 | $4K |
| 90734 | <1% | 196 | $4K | |
| 99381 | <1% | 44 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 34 | $3K |
| 90707 | <1% | 204 | $3K | |
| 90656 | <1% | 144 | $2K | |
| 86580 | <1% | 485 | $2K | |
| 90657 | <1% | 497 | $1K | |
| 90620 | <1% | 28 | $837.32 | |
| 90633 | <1% | 151 | $728.47 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $680.47 |
| 90647 | <1% | 353 | $604.51 | |
| 90715 | <1% | 75 | $501.42 | |
| 83655 | <1% | 89 | $434.12 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 28 | $422.36 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 31 | $370.26 |
| 90744 | <1% | 133 | $303.57 | |
| 81002 | <1% | 212 | $186.62 | |
| 90461 | <1% | 12 | $182.10 | |
| 97802 | <1% | 3,401 | $178.32 | |
| 81025 | <1% | 51 | $145.37 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $136.08 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 101 | $101.00 |
| 90680 | <1% | 14 | $88.64 | |
| 81000 | <1% | 40 | $53.47 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 35 | $39.32 |
| 36416 | 0% | 121 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.